Financhill
Back

X4 Pharmaceuticals Stock Predictions

X4 Pharmaceuticals Stock Forecast

  • Is X4 Pharmaceuticals Stock Undervalued?
    The current X4 Pharmaceuticals [XFOR] share price is $0.24. The Score for XFOR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • XFOR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will X4 Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

X4 Pharmaceuticals Stock Rating

Data Unavailable

X4 Pharmaceuticals Stock Price History

Is XFOR stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XFOR is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
x4pharma.com

52-Week Data

52-Week High:
1.60
52-Week Low:
0.23

Prediction Charts

Market Cap:
41.1M
Price in USD:
0.24
Volume:
2.1M
Beta:
0.60

Technical Analysis

SMA50:
0.43
SMA100:
0.49
SMA200:
0.59
52-Wk Change:
-82.99%

Stock Predictions

  • Is X4 Pharmaceuticals stock public?
    Yes, X4 Pharmaceuticals is a publicly traded company.
  • What is the X4 Pharmaceuticals stock quote today?
    The X4 Pharmaceuticals stock price is 0.24 USD today.
  • How to buy X4 Pharmaceuticals stock online?
    You can buy X4 Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-12 0.32 0.34 0.36 0.31
Mar-13 0.34 0.32 0.35 0.32
Mar-14 0.33 0.34 0.35 0.32
Mar-17 0.33 0.31 0.34 0.31
Mar-18 0.32 0.29 0.32 0.29
Mar-19 0.30 0.30 0.30 0.29
Mar-20 0.30 0.30 0.32 0.30
Mar-21 0.30 0.31 0.32 0.30
Mar-24 0.31 0.30 0.31 0.29
Mar-25 0.28 0.26 0.29 0.24
Mar-26 0.26 0.27 0.27 0.25
Mar-27 0.27 0.27 0.28 0.26
Mar-28 0.26 0.25 0.28 0.25
Mar-31 0.25 0.24 0.25 0.23

X4 Pharmaceuticals Earnings

Data Unavailable

X4 Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.30 per share, and an increase next year of $0.08 per share.

* X4 Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.